Placenta and obesity;Placenta et obésité

Medecine Therapeutique Endocrinologie et Reproduction

Volumn 7, Issue 4, 2005, Pages 287-291

  Guerre Millo, Michèle ^a   De Mouzon, Sylvie Hauguel ^b  

^a INSERM   (France)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 6; LEPTIN; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR;

CHRONIC INFLAMMATION; DIABETES MELLITUS; ENVIRONMENTAL FACTOR; HEREDITY; HUMAN; INSULIN RESISTANCE; OBESITY; PLACENTA; PREGNANCY DIABETES MELLITUS; REVIEW; MACROSOMIA; MATERNAL WELFARE; PREGNANCY;

EID: 27744477996     PISSN: 12959359     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (34)

1. Charles MA, Basdevant A, Eschwege E. Prevalence of obesity in adults in France: the situation in 2000 established from the OBEPI Study. Ann Endocrinol (Paris) 2002; 63: 154-8.
2. Barker DJ, Gluckman PD, Godfrey KM, Harding JE, Owens JA, Robinson J-S. Fetal nutrition and cardiovascular disease in adult life. Lancet 1993; 341: 938-41.
3. Phipps K, Barker DJ, Hales CN, Fall CH, Osmond C, Clark PM. Fetal growth and impaired glucose tolerance in men and women. Diabetologia 1993; 36: 225-8.
4. Barker DJ, Hales CN, Fall CH, Osmond C, Phipps K, Clark PM. Type 2 (non-insulin-dependent) diabetes mellitus, hypertension and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 1993; 36: 62-7.
5. Junien C, Gallou-Kabani C, Vige A, Gross MS. Nutritionnal epigenomics: consequences of unbalanced diets on epigenetics processes of programming during lifespan and between generations. Ann Endocrinol (Paris) 2005; 66: 2S19-2S28.
6. Junien C, Gallou-Kabani C, Vige A, Gross MS. Nutritional epigenomics of metabolic syndrome. Med Sci (Paris) 2005; 21: 396-404.
7. Catalano PM, Huston L, Amini SB, Kalhan SC. Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 1999; 180: 903-16.
8. Catalano PM. Obesity and pregnancy-the propagation of a viscous cycle? J Clin Endocrinol Metab 2003; 88: 3505-6.
9. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante Jr. AW. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest 2003; 112: 1796-808.
10. Xu H, Barnes GT, Yang Q, et al. Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance. J Clin Invest 2003; 112: 1821-30.
11. Curat CA, Miranville A, Sengenes C, et al. From blood monocytes to adipose tissue-resident macrophages: induction of diapedesis by human mature adipocytes. Diabetes 2004; 53: 1285-92.
12. Clement K, Viguerie N, Poitou C, et al. Weight loss regulates inflammation-related genes in white adipose tissue of obese subjects. FASEB J 2004; 18: 1657-69.
13. Cancello R, Henegar C, Viguerie N, et al. Reduction of macrophage infiltration and chemo-attractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss. Diabetes 2005; 54: 2277-86.
14. Guerre-Millo M. Adipose tissue and adipokines: for better or worse. Diabetes Metab 2004; 30: 13-9.
15. Bouloumie A, Curat CA, Sengenes C, Lolmede K, Miranville A, Busse R. Role of macrophage tissue infiltration in metabolic diseases. Curr Opin Clin Nutr Metab Care 2005; 8: 347-54.
16. Radaelli T, Varastehpour A, Catalano P, Hauguel-De Mouzon S. Gestational diabetes induces placental genes for chronic stress and inflammatory pathways. Diabetes 2003; 52: 2951-8.
17. Kirwan JP, Hauguel-De Mouzon S, Lepercq J, et al. TNF-{alpha} is a predictor of insulin resistance in human pregnancy. Diabetes 2002; 51: 2207-13.
18. Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman J-M. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372: 425-32.
19. Ahima RS, Flier J-S. Leptin. Annu Rev Physiol 2000; 62: 413-37.
20. Lepercq J, Challier JC, Guerre-Millo M, Cauzac M, Vidal H, Hauguel-De Mouzon S. Prenatal leptin production: evidence that fetal adipose tissue produces leptin. J Clin Endocrinol Metab 2001; 86: 2409-13.
21. Lepercq J, Guerre-Millo M, Andre J, Cauzac M, Hauguel-De Mouzon S. Leptin: a potential marker of placental insufficiency. Gynecol Obstet Invest 2003; 55: 151-5.
22. Lepercq J, Cauzac M, Lahlou N, et al. Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 1998; 47: 847-50.
23. Sierra-Honigmann MR, Nath AK, Murakami C, et al. Biological action of leptin as an angiogenic factor. Science 1998; 281: 1683-6.
24. Bouloumie A, Drexler HC, Lafontan M, Busse R. Leptin, the product of Ob gene, promotes angiogenesis. Circ Res 1998; 83: 1059-66.
25. Grosfeld A, Turban S, Andre J, et al. Transcriptional effect of hypoxia on placental leptin. FEBS Lett 2001; 502: 122-6.
26. Grosfeld A, Andre J, Hauguel-De Mouzon S, Berra E, Pouyssegur J, Guerre-Millo M. Hypoxia-inducible factor 1 transactivates the human leptin gene promoter. J Biol Chem 2002; 277: 42953-7.
27. Lepercq J, Taupin P, Dubois-Laforgue D, et al. Heterogeneity of fetal growth in type 1 diabetic pregnancy. Diabetes Metab 2001; 27: 339-44.
28. Ehrenberg HM, Mercer BM, Catalano PM. The influence of obesity and diabetes on the prevalence of macrosomia. Am J Obstet Gynecol 2004; 191: 964-8.
29. Hauguel-De Mouzon S, Lepercq J. Placental leptin and pregnancy pathologies. Gynecol Obstet Fertil 2001; 29: 534-7.
30. Catalano PM, Thomas A, Huston-Presley L, Amini SB. Increased fetal adiposity: a very sensitive marker of abnormal in utero development. Am J Obstet Gynecol 2003; 189: 1698-704.
31. Durnwald C, Huston-Presley L, Amini S, Catalano P. Evaluation of body composition of large-for-gestational-age infants of women with gestational diabetes mellitus compared with women with normal glucose tolerance levels. Am J Obstet Gynecol 2004; 191: 804-8.
32. Pettitt DJ, Nelson RG, Saad MF, Bennett PH, Knowler WC. Diabetes and obesity in the offspring of Pima Indian women with diabetes during pregnancy. Diabetes Care 1993; 16: 310-4.
33. Bjornholt JV, Erikssen G, Liestol K, Jervell J, Thaulow E, Erikssen J. Type 2 diabetes and maternal family history: an impact beyond slow glucose removal rate and fasting hyperglycemia in low-risk individuals? Results from 22.5 years of follow-up of healthy nondiabetic men. Diabetes Care 2000; 23: 1255-9.
34. Taleb S, Lacasa D, Bastard JP, et al. Cathepsin S, a novel biomarker of adiposity: relevance to atherogenesis. FASEB J 2005; 19: 1540-2.